Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
Close

Search

Subscribe
Death of Capsida trial studied to maintain viability of promising gene therapy
Health

Death of Capsida trial studied to maintain viability of promising gene therapy

Stephen Atcheler
By Stephen Atcheler
November 18, 2026 1 Min Read
Comments Off on Death of Capsida trial studied to maintain viability of promising gene therapy

Researchers on Friday presented detailed investigations into a gene therapy death that last year sparked fear and uncertainty among scientists who believed they had approached powerful treatments for a long list of brain diseases.

The researchers did not conclude precisely what led to the patient’s death, but proposed experiments to test future treatments.

“What I want everyone to take away is: I think we’re starting to build a framework to test this,” said Nicholas Flytzanis, director of research and innovation at Capsida Biotherapeutics. “I think it can be tested, and I think this new specific risk is one that we can try to mitigate and predict in the future.”

Exclusive STAT+ story

Already have an account? Log in

STAT+

STAT+

This article is reserved for STAT+ subscribers

Unlock this article – plus daily coverage and analysis of the biotech sector – by subscribing to STAT+.

Already have an account? Log in

See all packages

To read the rest of this story, subscribe to STAT+.

Subscribe

Gn Health

Views: 3
Stephen Atcheler
Author

Stephen Atcheler

**Stephen** is a staff journalist at **DailyVoxa**, specializing in business, finance, technology, artificial intelligence, and global markets. He is committed to delivering timely, accurate, and insightful reporting that helps readers understand the forces shaping the global economy and the rapidly evolving digital landscape.Drawing on in-depth research and credible sources, Stephen covers breaking developments, industry trends, and emerging innovations with a focus on clarity, balance, and factual accuracy. His reporting is designed to provide readers with reliable information, practical context, and thoughtful analysis without sensationalism.As a member of the DailyVoxa editorial team, Stephen follows the publication's Editorial Policy, Fact-Checking Policy, Corrections Policy, and Ethics Policy. Every article is carefully reviewed to ensure it meets the highest standards of journalistic integrity, transparency, and editorial independence.

Follow Me
Other Articles
Long-lost Georgia O'Keeffe painting sells for $4.8 million
Previous

Long-lost Georgia O’Keeffe painting sells for $4.8 million

Jeff Bezos says he was 'heavily involved' in choosing Robert Pattinson as new 007 - BBC News Africa
Next

Jeff Bezos says he was ‘heavily involved’ in choosing Robert Pattinson as new 007 – BBC News Africa

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.
  • About Us
  • Accessibility Statement
  • Advertise With Us
  • AI Usage & Transparency Policy
  • Contact us
  • Cookie Policy
  • Corrections Policy
  • Meet Our Team
  • Privacy Policy
    • Disclaimer
    • DMCA & Copyright Policy
    • Editorial Policy
    • Ethics Policy
    • Fact-Checking Policy
  • Terms and Conditions
Copyright 2026 — Today's News. Tomorrow's Perspective.. All rights reserved.